India to Introduce First Approved Dengue Vaccine QDENGA by Mid-2027
| Key Information | Details |
|---|---|
| Vaccine Name | QDENGA (TAK-003) |
| Developed By | Takeda (Japanese pharmaceutical company) |
| Approval | Approved by CDSCO (India) in July 2026 |
| Protection Against | DENV-1, DEN-2, DENV-3, DENV-4 |
| Dosage | Two doses, 3 months apart |
| Prevention Measures Alongside | Mosquito control, reducing breeding sites, avoiding Aedes mosquito exposure |